Innovis Asset Management LLC Ambrx Biopharma Inc. Transaction History

Innovis Asset Management LLC

  • $260 Billion
  • Q3 2023

A detailed history of Innovis Asset Management LLC transactions in Ambrx Biopharma Inc. stock. As of the latest transaction made, Innovis Asset Management LLC holds 31,137 shares of AMAM stock, worth $871,836. This represents 0.14% of its overall portfolio holdings.

Number of Shares
31,137
Previous 16,826 85.05%
Holding current value
$871,836
Previous $277 Million 29.29%
% of portfolio
0.14%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$9.3 - $16.6 $133,092 - $237,562
14,311 Added 85.05%
31,137 $358 Million
Q2 2023

Aug 03, 2023
BUY
$7.66 - $16.46 $128,887 - $276,955
16,826 New
16,826 $277 Million

Others Institutions Holding AMAM

# of Institutions
2
Shares Held
31.2K
Call Options Held
0
Put Options Held
0
View Full List

About Ambrx Biopharma Inc.

AMAM Quotes by TradingView
  • Ticker AMAM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,618,400
  • Market Cap $1.08B
  • Description
  • Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...
More about AMAM
Track This Portfolio

Track Innovis Asset Management LLC Portfolio

Follow Innovis Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Innovis Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Innovis Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email